A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
Active, not recruiting · NCT01396408 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours | Advanced Rare Tumours | Active, not recruiting | Phase 2 | 2026-08-11 | NCT01396408 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Cancer Trials Group | 73 |
| Pfizer | 431 |
17 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Allan Blair Cancer Centre | Regina | Canada | 76 |
| BCCA - Cancer Centre for the Southern Interior | Kelowna | Canada | 4 |
| BCCA - Vancouver Cancer Centre | Vancouver | Canada | 11 |
| CancerCare Manitoba | Winnipeg | Canada | 98 |
| CHU Sainte-Justine | Montreal | Canada | 36 |
| CHUM - Hopital Notre-Dame | Montreal | Canada | 10 |
| Cross Cancer Institute | Edmonton | Canada | 146 |
| Hospital for Sick Children | Toronto | Canada | 76 |
| Izaak Walton Killam (IWK) Health Centre | Halifax | Canada | 2 |
| Juravinski Cancer Centre at Hamilton Health Sciences | Hamilton | Canada | 60 |
| London Regional Cancer Program | London | Canada | 40 |
| McGill University - Dept. Oncology | Montreal | Canada | 1 |
| Ottawa Hospital Research Institute | Ottawa | Canada | 46 |
| QEII Health Sciences Centre | Halifax | Canada | 11 |
| Saskatoon Cancer Centre | Saskatoon | Canada | 75 |
| Tom Baker Cancer Centre | Calgary | Canada | 29 |
| Univ. Health Network-Princess Margaret Hospital | Toronto | Canada | 1 |